Clinical Trial Update: Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and immunogenicity of V2 apex-directed RNA immunogens DV201P-RNA and DV202B1-RNA in adults without HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• DV201P-RNA
• DV202B1-RNA

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: RECRUITING